- Home
- MOMO vs GHRS Comparison
MOMO vs GHRS Comparison
Compare MOMO & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOMO
- GHRS
- Stock Information
- Founded
- MOMO 2011
- GHRS 2018
- Country
- MOMO China
- GHRS Ireland
- Employees
- MOMO N/A
- GHRS N/A
- Industry
- MOMO Computer Software: Prepackaged Software
- GHRS Biotechnology: Pharmaceutical Preparations
- Sector
- MOMO Technology
- GHRS Health Care
- Exchange
- MOMO Nasdaq
- GHRS Nasdaq
- Market Cap
- MOMO 909.4M
- GHRS 737.5M
- IPO Year
- MOMO 2014
- GHRS 2021
- Fundamental
- Price
- MOMO $8.53
- GHRS $15.30
- Analyst Decision
- MOMO Buy
- GHRS Strong Buy
- Analyst Count
- MOMO 2
- GHRS 8
- Target Price
- MOMO $10.00
- GHRS $30.63
- AVG Volume (30 Days)
- MOMO 1.5M
- GHRS 194.5K
- Earning Date
- MOMO 09-02-2025
- GHRS 09-02-2025
- Dividend Yield
- MOMO 3.51%
- GHRS N/A
- EPS Growth
- MOMO N/A
- GHRS N/A
- EPS
- MOMO 1.06
- GHRS N/A
- Revenue
- MOMO $1,450,201,337.00
- GHRS N/A
- Revenue This Year
- MOMO $0.97
- GHRS N/A
- Revenue Next Year
- MOMO $4.25
- GHRS N/A
- P/E Ratio
- MOMO $8.29
- GHRS N/A
- Revenue Growth
- MOMO N/A
- GHRS N/A
- 52 Week Low
- MOMO $5.12
- GHRS $6.00
- 52 Week High
- MOMO $8.94
- GHRS $20.50
- Technical
- Relative Strength Index (RSI)
- MOMO 62.12
- GHRS 65.01
- Support Level
- MOMO $8.25
- GHRS $14.20
- Resistance Level
- MOMO $8.94
- GHRS $15.47
- Average True Range (ATR)
- MOMO 0.26
- GHRS 1.06
- MACD
- MOMO -0.07
- GHRS 0.24
- Stochastic Oscillator
- MOMO 37.14
- GHRS 89.23
About MOMO Hello Group Inc.
Hello Group Inc provides mobile-based social networking services. It enables users to establish and expand social relationships based on location and interests. Its platform includes the Momo mobile application and a variety of related features, functionalities, tools, and services that it provides to users, customers, and platform partners. The company derives its revenue from live video services, value-added services, mobile marketing services, mobile games, and other services. It operates in three segments: Momo's service lines, Tantan's service lines, and QOOL's service lines, out of which Momo's service lines segment derives the majority of revenue.
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.